Clinical Trial Update: Study of Urinary Angiotensinogen as a Marker to Warn the Deterioration of Renal Function in CKD Patients Early.

View source ↗

Summary

A clinical trial from Fudan University is evaluating urinary angiotensinogen as an early biomarker to warn of renal function deterioration in chronic kidney dis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Snippet

Sponsor: Fudan University | Conditions: Chronic Kidney Disease, Urinary Angiotensinogen | Status: UNKNOWN